Description

Teicoplanin CAS NO 61036-62-2 is a complex glycopeptide antibiotic belonging to the same class as vancomycin. It is a critical agent in the fight against severe Gram-positive bacterial infections, particularly those caused by methicillin-resistant *Staphylococcus aureus* (MRSA). This product is essential for pharmaceutical manufacturers and research institutions developing advanced antibacterial therapies and diagnostic tools. Its role is pivotal in hospital settings for treating complicated skin infections, bacteremia, and other life-threatening conditions.

Application

• Pharmaceutical Active Ingredient (API): Core component in the formulation of injectable antibiotics for systemic infections.
• Medical Research & Development: Used in microbiological studies, mechanism of action research, and development of new antibacterial agents.
• In-vitro Diagnostics: Serves as a reference standard in susceptibility testing (e.g., broth microdilution, agar diffusion) and quality control for culture media.
• Veterinary Medicine: Applied in the treatment of serious bacterial infections in animals, following appropriate regulatory guidelines.
• Biochemical Research: Utilized as a tool compound to study bacterial cell wall synthesis and peptidoglycan assembly.

Basic Information

Product Name	Teicoplanin
CAS No.	61036-62-2
Molecular Formula	C72H88Cl2N8O33
Molecular Weight	~ 1564.3 g/mol (for Teicoplanin A2)
Synonyms	Teicoplanin A2; Teichomycin A2; MDL 507; Targocid; Teicoplanin complex; Antibiotic MDL 507; (4S)-4-[[(2S,3R,4S,5S,6R)-5-Acetamido-4-[[(2R,3R,4R,5R,6S)-5-Acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy]-6-[(1R,2R)-1,2-dihydroxyethyl]-3-hydroxyoxan-2-yl]methoxy]-19,31-dichloro-7,22,28,30,32-pentahydroxy-3,5,7,11,13,15,37-heptaoxo-18,39-dioxa-4,6,8,12,14,16-hexaazaoctacyclo[14.14.11.22,9.03,38.04,36.05,34.010,33.017,27]nonatriaconta-20,23,25(38),26,29,31,33(39),34,36-nonaene-21-carboxylic acid
EINECS	262-582-6

Quality Control

Our Teicoplanin is manufactured and tested under strict quality management systems. Each batch is subjected to comprehensive analytical testing, including HPLC for purity and potency, to ensure it meets high-grade pharmaceutical standards. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting identity, purity, assay, and related substances. We support compliance with cGMP, ICH Q7 guidelines, and relevant pharmacopoeial standards (e.g., USP, EP) for API manufacturing.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic nature, the container must be kept tightly sealed in a dry environment to prevent moisture absorption, which can affect stability and potency. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to pale yellow amorphous powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 95.0% (on anhydrous basis)
Water (Karl Fischer)	≤ 10.0%
pH (1% solution)	3.5 - 6.0
Related Substances (HPLC)	Total impurities ≤ 5.0% Any single impurity ≤ 2.0%
Residual Solvents (GC)	Complies with ICH Q3C
Bacterial Endotoxins	< 1.0 EU/mg
Sterility (where applicable)	Sterile

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.